A real-world analysis on the efficacy and tolerability of liposomal irinotecan plus 5-fluorouracil and folinic acid in metastatic pancreatic ductal adenocarcinoma in Belgium.

Lise VerbruggenLisa VerheggenGreetje VanhoutteCatherine LolyWillem LybaertIvan BorbathPhilippe VergauweKoen HendrickxCeline DebeuckelaereAmy de Haar-HollemanJean-Luc Van LaethemMarc Peeters

Published in: Therapeutic advances in medical oncology (2023)

Retrospective study on the efficacy and tolerability of liposomal irinotecan (NALIRI); ClinicalTrials.gov Identifier: NCT0509506 (https://clinicaltrials.gov/ct2/show/NCT05095064?term=naliri&draw=2&rank=2).

Keyphrases

open label
squamous cell carcinoma
small cell lung cancer
computed tomography
preterm infants
magnetic resonance imaging
double blind
image quality
randomized controlled trial
clinical trial
magnetic resonance
dual energy
gestational age
preterm birth